KC Anderson

4.9k citations

82 papers · 3.8k indexed · h-index 32

Impact in

Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
Genetics top 1%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 50
- Multiple Myeloma Research and Treatments 34
- Hematopoietic Stem Cell Transplantation 14
Genetics 16
- Chronic Lymphocytic Leukemia Research 11

Co-authors: Dharminder Chauhan Hiroshi Uchiyama BA Barut Mitsuyoshi Urashima Yasmin Akbarali Ken Yamamoto Towia A. Libermann LM Nadler
Journals: Blood (41 papers)Leukemia (4 papers)Transfusion (3 papers)Journal of Clinical Oncology (3 papers)Journal of Immunotherapy (1 paper)
Partner nations: United States United Kingdom Germany

In The Last Decade

KC Anderson

82 papers receiving 3.7k citations

Peers

Countries citing papers authored by KC Anderson

Since Specialization

Citations

This map shows the geographic impact of KC Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KC Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KC Anderson more than expected).

Fields of papers citing papers by KC Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KC Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KC Anderson. The network helps show where KC Anderson may publish in the future.

Co-authors

The 25 scholars most cited alongside KC Anderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with KC Anderson Line = papers co-authored together KC Anderson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma Haematologica ·Meletios Α. Dimopoulos, Robert Z. Orlowski, T. Facon, Pieter Sonneveld, KC Anderson, Meral Beksaç, Lotfi Benboubker, Huw Roddie, Anna Potamianou, Catherine Couturier, H. Feng, Ö. Ataman, Helgi van de Velde, Paul G. Richardson	2014	23
2	Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies Current Cancer Drug Targets ·Klaus Podar, KC Anderson	2011	14
3	Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma Leukemia ·Paola Neri, Pierfrancesco Tassone, Masood A. Shammas, Hiroshi Yasui, Ernestina Schipani, Ramesh B. Batchu, Simona Blotta, Rao Prabhala, Laurence Catley, Maho Hamasaki, Teru Hideshima, Dharminder Chauhan, Gary S. Jacob, Donald Picker, Salvatore Venuta, KC Anderson, Nikhil C. Munshi	2007	18
4	Targeting mitochondria to overcome conventional and Bortezomib-resistance in multiple myeloma cells. Blood ·D Chauhan, GL Li, Klaus Podar, Teru Hideshima, M. Kelly Nicholas, M Constatntine, Laurence Catley, NC Munshi, KC Anderson	2003	2
5	Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of b1-integrin and phosphatidylinositol 3-kinase/AKT signaling beta. Blood ·YT Tai, Klaus Podar, L Catley, YH Tseng, Reshma Shringarpure, Renate Burger, Masaharu Akiyama, Teru Hideshima, D Chauhan, Nicholas Mitsiades, Paul Richardson, NC Munshi, C.Ronald Kahn, Constantine S. Mitsiades, KC Anderson	2003	33
6	Gene expression analysis of tumor cells sensitive and resistant to PS-341 (Bortezomib) treatment: Clinical implications. Blood ·Reshma Shringarpure, D Chauhan, Renate Burger, L Catley, YT Tai, Klaus Podar, Teru Hideshima, Nicholas Mitsiades, C Mitsiades, KC Anderson	2003	1
7	Critical role for Hck-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin-6-induced proliferation and survival of multiple myeloma cells. Blood ·Klaus Podar, Gustavo Mostoslavsky, YT Tai, Martin Sattler, Taichi Hayashi, LP Catley, Teru Hideshima, R J Mulligan, D Chauhan, KC Anderson	2003	1
8	Thalidomide analogue IMiD3 provides T cell co-stimulation through B7-CD28 pathway. Blood ·Richard LeBlanc, Teru Hideshima, Tateki Hayashi, LP Catley, Renate Burger, Reshma Shringarpure, P. Cheema, Paul G. Richardson, KC Anderson, NC Munshi	2002	1
9	Heat shock protein-27 confers drug-resistance in multiple myeloma cells. Blood ·D Chauhan, GL Li, Teru Hideshima, Klaus Podar, L Catley, Richard LeBlanc, Nicholas Mitsiades, C Mitsiades, PG Richardson, Satya Saxena, KC Anderson	2002	2
10	Proteasome inhibitor PS-341 inhibits human multiple myeloma cell growth in a murine model. Blood ·Richard LeBlanc, LP Catley, Teru Hideshima, CS Pien, PJ Elliott, KC Anderson	2001	11
11	2-methoxyestradiol (2ME2) acts directly on tumor cells and in the bone marrow microenvironment to overcome drug resistance in multiple myeloma (MM) cells. Blood ·D Chauhan, Michael Sattler, GL Li, Teru Hideshima, Richard LeBlanc, L Catley, Deepti Gupta, PG Richardson, RL Schlossman, NC Munshi, KC Anderson	2001	3
12	beta-Lapachone is safe and effective in Biege-Nude-Xid mouse xenograft model of human plasmacytoma. Blood ·Tapas K. Das Gupta, Richard LeBlanc, LP Catley, Klaus Podar, BK Lin, YT Tai, D Chauhan, Teru Hideshima, KC Anderson	2001	1
13	A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM). Blood ·PG Richardson, RL Schlossman, Teru Hideshima, Faith E. Davies, Richard LeBlanc, Laurence Catley, Deborah Doss, Kelly Ka, Mary McKenney, Julie Mechlowicz, Andrea Freeman, Reggie Deocampo, Rebecca L. Rich, Joan J. Ryoo, Deepika Chauhan, NC Munshi, Edie Weller, Sheeba Thomas, Jerome B. Zeldis, KC Anderson	2001	23
14	CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin’s lymphoma Bone Marrow Transplantation ·RJ Soiffer, AS Freedman, Donna Neuberg, DC Fisher, E. Alyea, John G. Gribben, RL Schlossman, L Bartlett-Pandite, Caroline Kuhlman, Christine Murray, Andrea Freeman, P Mauch, KC Anderson, LM Nadler, Jerome Ritz	1998	32
15	High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. Journal of Clinical Oncology ·Arnold S. Freedman, Donna Neuberg, John G. Gribben, Peter Mauch, Robert J. Soiffer, David C. Fisher, KC Anderson, N.S. Andersen, RL Schlossman, M Kroon, Jerome Ritz, Jon C. Aster, Lee M. Nadler	1998	143
16	Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering Transfusion ·Iain J. Webb, F Coral, J. W. Andersen, AD Elias, Robert W. Finberg, Lee M. Nadler, Jerome Ritz, KC Anderson	1996	64
17	Transfusion practices in human immunodeficiency virus‐infected patients Transfusion ·Mark A. Popovsky, Kathleen F. Benson, Armand B. Glassman, Heather Hume, Harold A. Oberman, Patricia Pisciotto, KC Anderson	1995	23
18	Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion Blood ·Hiroshi Uchiyama, BA Barut, AF Mohrbacher, Dharminder Chauhan, KC Anderson	1993	359
19	Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. Journal of Clinical Oncology ·AS Freedman, Tak Takvorian, KC Anderson, Peter Mauch, S N Rabinowe, K Blake, B.Y. Yeap, Robert J. Soiffer, F Coral, Lara Heflin	1990	147
20	Mechanical properties of the colon: comparison of the features of the African and European colon in vitro. Gut ·David Watters, A. N. Smith, M. A. Eastwood, KC Anderson, R. A. Elton, J W Mugerwa	1985	93

About KC Anderson

KC Anderson is a scholar working on Hematology, Genetics, Immunology and Allergy, Pathology and Forensic Medicine and Immunology, having authored 82 papers that have together received 3.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (34 papers), Hematopoietic Stem Cell Transplantation (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Protein Degradation and Inhibitors (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Immune Cell Function and Interaction (8 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Hematology (2.0k citations), Genetics (710 citations), Oncology (1.5k citations), Pathology and Forensic Medicine (760 citations) and Immunology (817 citations). KC Anderson has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Dharminder Chauhan, Hiroshi Uchiyama, BA Barut, Mitsuyoshi Urashima, Yasmin Akbarali, Ken Yamamoto, Towia A. Libermann, LM Nadler, SF Schlossman and DC Fisher. Their work appears in journals such as Blood, Leukemia, Transfusion, Journal of Clinical Oncology and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact